Susquehanna Fundamental Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $24.5M | Buy |
23,286
+22,006
| +1,719% | +$23.1M | 0.56% | 39 |
|
|
2024
Q1 | $1.23M | Buy |
+1,280
| New | +$1.23M | 0.06% | 313 |
|
|
2023
Q4 | – | Sell |
-5,488
| Closed | -$4.52M | – | 270 |
|
|
2023
Q3 | $4.52M | Sell |
5,488
-8,523
| -61% | -$7.01M | 0.29% | 94 |
|
|
2023
Q2 | $10.1M | Hold |
14,011
| – | – | 0.37% | 78 |
|
|
2023
Q1 | $11.5M | Sell |
14,011
-6,159
| -31% | -$5.06M | 0.27% | 109 |
|
|
2022
Q4 | $14.6M | Sell |
20,170
-1,245
| -6% | -$898K | 0.25% | 117 |
|
|
2022
Q3 | $14.8M | Buy |
+21,415
| New | +$14.8M | 0.25% | 97 |
|
|
2022
Q1 | – | Sell |
-5,059
| Closed | -$3.2M | – | 1668 |
|
|
2021
Q4 | $3.2M | Sell |
5,059
-2,483
| -33% | -$1.57M | 0.08% | 302 |
|
|
2021
Q3 | $4.56M | Buy |
7,542
+2,747
| +57% | +$1.66M | 0.08% | 318 |
|
|
2021
Q2 | $2.68M | Sell |
4,795
-20,708
| -81% | -$11.6M | 0.05% | 504 |
|
|
2021
Q1 | $12.1M | Buy |
25,503
+13,833
| +119% | +$6.54M | 0.21% | 120 |
|
|
2020
Q4 | $5.64M | Buy |
11,670
+9,970
| +586% | +$4.82M | 0.1% | 279 |
|
|
2020
Q3 | $952K | Buy |
+1,700
| New | +$952K | 0.03% | 659 |
|